Rapid development of acute monocytic leukemia (AML-M5b) with t(9;11)(p22;q23) after chemotherapy for T-cell lymphoblastic lymphoma: A case report
Patients with T-LBL progression to AML have a poor prognosis and shorter overall survival. Hence, exploring the pathogenic mechanisms and reasons for disease progression has significant implications for finding effective treatment modalities and prolonging patient survival.
Authors
- Fang-yi Fan
- Lei Ma (ORCID: https://orcid.org/0000-0002-8390-3242)
- Jiao Cai (ORCID: https://orcid.org/0000-0002-4105-6081)
- Nan Zhang (ORCID: https://orcid.org/0000-0002-5877-1786)
- Dan Chen (ORCID: https://orcid.org/0000-0002-7055-141X)
- Ling Qiu (ORCID: https://orcid.org/0000-0002-4648-2880)
- Mengjiao Li (ORCID: https://orcid.org/0000-0002-2305-5886)
- Shi-Hui Ren
- Bai-Tao Dou
- Hao Yao
Institutions
- North Sichuan Medical University (CN)
- Chengdu Military General Hospital (CN)
- Chinese People's Liberation Army (CN)
Publication Details
- Journal
- Heliyon
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1016/j.heliyon.2025.e42537
- Citations
- 1
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 1.77
Funders
- Sichuan Province Science and Technology Support Program